Labeled RNA samples were prepared according to the manufacturer’s manual (Affymetrix, Santa Clara, CA).
11 A labeled cRNA probe was prepared from the 16 highest-quality total RNA samples (two replicates per treatment/tissue/strain), and run on a total of 16 mouse genome microarrays (Mouse Genome 430A_v2.0 GeneChips; Affymetrix). We followed the manufacturer’s protocol for small sample which required only 0.100 μg of RNA/sample (GeneChip Eukaryotic Small Sample Target Labeling Protocol; Affymetrix). Hybridization, washing, and staining were performed on the fluidics station (GeneChip Fluidics Station 400; Affymetrix) according to the manufacturer’s standard protocols. Hybridized microarrays were then scanned using a microarray scanner (Agilent GeneArray Scanner; Agilent Technologies, Inc.).
The acquisition, processing, and basic analysis of microarray-generated data were performed using the manufacturer’s gene expression analysis software (Affymetrix Gene Chip Operating Software [GCOS] and Gene Chip RNA Expression Analysis Software [GREX]), and raw data were normalized based on 100 housekeeping genes present on the microarray, and scaled to an average median signal value of 500. The GCOS algorithm was used to evaluate the abundance of each transcript represented on the array and labeled it as present (P), absent (A), or marginal (M). Comparison of normoxic and hyperoxic data was performed with GREX software (Affymetrix) generating signal log ratios (SigLogRatios) and significance estimates. SigLogRatios for biological replicates were averaged and SDs were calculated. Generally, SigLogRatio values greater or equal to 0.5 were considered to show upregulation, values smaller or equal to −0.5 downregulated, and values in between −0.5 and 0.5 as no change (NC), although GREX data analysis algorithm would make the final call taking into account the given probe’s signal/noise ratio.